mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
6e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |